How much funding has Eaglenos raised?

Eaglenos has raised $21.2M in total funding, most recently a Series A round.

Who are Eaglenos's investors?

Eaglenos's investors include 3E Bioventures Capital.

Where is Eaglenos headquartered?

Eaglenos is headquartered in Nanjing, China.

What industry is Eaglenos in?

Eaglenos operates in Biotech, Healthcare.

How many employees does Eaglenos have?

Eaglenos has 201-500 employees.

Eaglenos

Pioneering precision health management through innovative diagnostics

Nanjing, China · Founded 2018 · $21.2M raised

Biotech

Healthcare

Headquarters: Nanjing
Employees: 201–500
Founded: 2018
Business Model: B2B

Website: eaglenos.com
Total Funding: $21.2M
Last Round: $21.2M Series AMay 2023
Rounds: 1

About

Eaglenos (南京晶捷生物科技有限公司) is a Nanjing, China-based medical device and diagnostics company founded in 2018, specializing in portable point-of-care testing (POCT) devices and personalized health management products. The company develops electrochemical detection platforms, precision sensor materials, and structural diagnostic systems for both human and veterinary healthcare markets. With over 200 employees, 21+ CE certifications, and 76+ authorized patents, Eaglenos delivers reliable diagnostic devices for clinical, workplace, and consumer health settings globally.

Summary

Eaglenos is a Biotech company based in Nanjing, China, founded in 2018. It has raised $21.2M in total across 1 round, most recently a $21.2M Series A round in May 2023. Investors include 3E Bioventures Capital.